HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
Harmony Biosciences Holdings (Nasdaq: HRMY) has announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Harmony Biosciences Holdings (Nasdaq: HRMY) has announced its participation in two upcoming investor conferences. The company's management team will be present at:
1. The Wells Fargo 2024 Healthcare Conference in Boston, with a fireside chat scheduled for Thursday, September 5, 2024, at 9:30 a.m. ET.
2. The 2024 Cantor Global Healthcare Conference in New York City, featuring a fireside chat on Tuesday, September 17, 2024, at 3:05 p.m. ET.
Investors and interested parties can access webcasts of both fireside chats through the investor page of Harmony's website at https://ir.harmonybiosciences.com/.
Details
News Market Reaction – HRMY
The recorded move for HRMY in the trading session of this news was +2.79%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Wells Fargo 2024 Healthcare Conference
- Location:
Boston - Fireside Chat: Thursday, September 5, 2024, at 9:30 a.m. ET
2024 Cantor Global Healthcare Conference
- Location:
New York City - Fireside Chat: Tuesday, September 17, 2024, at 3:05 p.m. ET
A webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.
About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciplines and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
bdoyle@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-302225692.html
SOURCE Harmony Biosciences
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.